×
ADVERTISEMENT
ADVERTISEMENT

FDA approves Novavax Covid vaccine with new conditions

According to the approval letter, the license restricts the use of the vaccine called Nuvaxovid to individuals aged 65 and older, and those between 12 and 64 who have at least one underlying condition that increases their risk of developing severe illness from Covid.
Last Updated : 18 May 2025, 03:42 IST
ADVERTISEMENT

Follow Us :

Comments
ADVERTISEMENT
Published 18 May 2025, 03:42 IST

Follow us on :

Follow Us